Monday, May 30, 2016

BRIEF-Genmab achieves $30 mln milestone in deal with Janssen

* Says milestone triggered by first commercial sale of

Darzalex in Europe

Source text for Eikon:

Further company coverage:

(Copenhagen newsroom)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)